Core Points - The document outlines the share repurchase management system of Guangzhou Maipu Regenerative Medicine Technology Co., Ltd, aiming to standardize share repurchase behavior, maintain market order, and protect the rights of investors and the company [1][2]. Group 1: General Principles - The share repurchase management system is established based on various laws and regulations, including the Company Law and Securities Law of the People's Republic of China [1]. - The company must ensure that share repurchases do not harm the legitimate rights and interests of shareholders and creditors, and must establish effective internal control systems [3][4]. Group 2: Conditions for Share Repurchase - The company can repurchase shares under specific circumstances, such as reducing registered capital, employee stock ownership plans, or when the stock price falls below certain thresholds [2][3]. - Conditions for repurchase include the stock being listed for at least six months and the company having no major legal violations in the past year [10]. Group 3: Implementation Procedures - The board of directors must carefully evaluate the company's financial status and ensure that the repurchase plan aligns with the company's actual financial situation [4][27]. - The repurchase plan must include details such as the purpose, method, price range, and funding sources [33][20]. Group 4: Disclosure Requirements - The company must disclose the repurchase plan and any changes to it, ensuring transparency with shareholders and regulatory bodies [36][38]. - Regular updates on the progress of the repurchase must be provided, including the number of shares repurchased and the total amount spent [36][29]. Group 5: Handling of Repurchased Shares - Repurchased shares must be handled according to the disclosed purposes, either being canceled or transferred as per legal requirements [40][46]. - The company must notify creditors if it plans to cancel repurchased shares [18].
迈普医学: 回购股份管理制度（2025年5月）